Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2007-06-11

Clinical Trial Update: Modeling Genotype and Other Factors to Enhance the Safety of Coumadin Prescribing [NA]

View source ↗

Summary

This clinical trial update discusses modeling genotype and other factors to improve the safety of warfarin (Coumadin) prescribing. It covers potential use acros…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Coumadin (warfarin)

Snippet

Sponsor: Agency for Healthcare Research and Quality (AHRQ) | Conditions: Atrial Fibrillation, Deep Venous Thrombosis | NA | Status: UNKNOWN